BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Topics
»
Disease categories and therapies
» Urology
Urology
RSS
Long-term and post hoc phase III data presented on mirabegron
Feb. 28, 2012
Resiniferatoxin improves urodynamic parameters in patients with overactive bladder
Feb. 28, 2012
Merck & Co. patents novel beta3-adrenoceptor agonists
Feb. 23, 2012
Preparations begin for European trial of NX-1207
Feb. 22, 2012
Ongoing phase III trials of NX-1207 show no safety concerns
Feb. 17, 2012
German marketing collaboration signed for Vitaros
Feb. 17, 2012
Nippon Chemiphar patents new candidate therapies for urinary incontinence
Feb. 15, 2012
New E-NPP 2 inhibitors patented by Ono Pharmaceutical
Feb. 10, 2012
Recordati presents new metabotropic glutamate mGlu5 receptor antagonists
Feb. 9, 2012
Japanese approval for new formulation of Fosrenol
Feb. 3, 2012
Previous
1
2
…
101
102
103
104
105
106
107
108
109
…
318
319
Next
RSS